Page 3 - Compass Pathways News Today

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) major shareholder George Jay Goldsmith sold 25,750 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of $8.96, for a total value of $230,720.00. Following the completion of the sale, the insider now directly owns 4,010,404 shares […]

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) major shareholder George Jay Goldsmith sold 25,750 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $8.96, for a total value of $230,720.00. Following the transaction, the insider now directly owns 4,010,404 shares of the […]

Here are the biggest calls on Wall Street on Monday.

Morgan Stanley initiated coverage on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a report issued on Monday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $30.00 price objective on the stock. Other equities research analysts have also recently issued reports about the company. HC Wainwright reiterated a buy rating and […]

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday.

David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 -- Compass Pathways plc , a biotechnology company dedicated to...

Shares of Compass Pathways plc (CMPS) are slipping over 7% after the company announced that board Chairman and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia will step down from the Board of Directors.

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) saw an uptick in trading volume on Thursday . 358,701 shares traded hands during mid-day trading, a decline of 46% from the previous session’s volume of 666,186 shares.The stock last traded at $8.90 and had previously closed at $9.50. Analyst Ratings Changes Several research firms recently issued […]

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

By Ben Glickman Shares of Compass Pathways sank Thursday after the company warned it was experiencing delays in one of its trials. The stock was down 18% to...